Pfizer and Wyeth have entered into an agreement with Boehringer Ingelheim to divest certain animal health assets, pending Pfizer’s acquisition of Wyeth. Under the agreement, BI will acquire products, research and manufacturing facilities, located in Fort Dodge, IA, as well as related assets and intellectual property, primarily from Wyeth’s Fort Dodge Animal Health portfolio in the U.S. and Canada. Products include cattle and small animal vaccines and some animal health pharmaceuticals. BI also p...